# Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs

> **NCT02458040** · — · WITHDRAWN · sponsor: **Assistance Publique - Hôpitaux de Paris**

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Drug selected in the study

## Key facts

- **NCT ID:** NCT02458040
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458040, "Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02458040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*